Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin + Artesunate vs Artemether-lumefantrine in Uncomplicated Malaria
NCT00694694Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Jun 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of azithromycin in malaria (2 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Parasitological failure rate at 28 days. Started Jun 2008; status: completed.
02
Drugs
azithromycin
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00694694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00694694.